Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Integrating a 19F MRI Tracer Agent into the Clinical Scale Manufacturing of a T-Cell Immunotherapy.

O'Hanlon CF, Fedczyna T, Eaker S, Shingleton WD, Helfer BM.

Contrast Media Mol Imaging. 2017 Nov 2;2017:9548478. doi: 10.1155/2017/9548478. eCollection 2017.

2.

Fluorine-19 Labeling of Stromal Vascular Fraction Cells for Clinical Imaging Applications.

Rose LC, Kadayakkara DK, Wang G, Bar-Shir A, Helfer BM, O'Hanlon CF, Kraitchman DL, Rodriguez RL, Bulte JW.

Stem Cells Transl Med. 2015 Dec;4(12):1472-81. doi: 10.5966/sctm.2015-0113. Epub 2015 Oct 28.

3.

Clinical cell therapy imaging using a perfluorocarbon tracer and fluorine-19 MRI.

Ahrens ET, Helfer BM, O'Hanlon CF, Schirda C.

Magn Reson Med. 2014 Dec;72(6):1696-701. doi: 10.1002/mrm.25454. Epub 2014 Sep 19.

4.

A novel probe for the non-invasive detection of tumor-associated inflammation.

Balducci A, Wen Y, Zhang Y, Helfer BM, Hitchens TK, Meng WS, Wesa AK, Janjic JM.

Oncoimmunology. 2013 Feb 1;2(2):e23034.

5.

¹⁹F MRI tracer preserves in vitro and in vivo properties of hematopoietic stem cells.

Helfer BM, Balducci A, Sadeghi Z, O'Hanlon C, Hijaz A, Flask CA, Wesa A.

Cell Transplant. 2013;22(1):87-97. doi: 10.3727/096368912X653174. Epub 2012 Aug 2.

PMID:
22862925
6.

Visualizing arthritic inflammation and therapeutic response by fluorine-19 magnetic resonance imaging (19F MRI).

Balducci A, Helfer BM, Ahrens ET, O'Hanlon CF 3rd, Wesa AK.

J Inflamm (Lond). 2012 Jun 21;9(1):24. doi: 10.1186/1476-9255-9-24.

7.

Functional assessment of human dendritic cells labeled for in vivo (19)F magnetic resonance imaging cell tracking.

Helfer BM, Balducci A, Nelson AD, Janjic JM, Gil RR, Kalinski P, de Vries IJ, Ahrens ET, Mailliard RB.

Cytotherapy. 2010 Apr;12(2):238-50. doi: 10.3109/14653240903446902.

Supplemental Content

Loading ...
Support Center